FCER2 and AIDS: Increased serum/plasma levels of molecules involved in B-cell activation, among which soluble (s)CD23, sCD27, sCD30, sCD44, and CXCL13, have been associated with the development of acquired immune deficiency syndrome (AIDS)-related BCL2–7.